X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/markets/europe/spains-pharmamar-says-potential-covid-19-treatment-shows-efficacy-against-2022-01-11/
http://www.pmlive.com/pharma_news/pharmamars_cancer_drug_has_potent_preclinical_efficacy_against_covid-19_1362250
https://www.reuters.com/article/us-health-coronavirus-spain-pharmamar/pharmamar-plans-phase-iii-trial-of-cancer-drug-for-covid-19-shares-jump-idUSKBN2710Y6
http://pharmamar.com/wp-content/uploads/2020/07/PR_plitidepsin_in_vitro_results_Korea_OK.pdf
https://www.sciencealert.com/there-are-nearly-50-already-approved-drugs-that-could-help-us-fight-covid-19
https://www.yahoo.com/lifestyle/pharmamar-announced-spanish-medicines-agency-103500242.html
https://www.prnewswire.com/news-releases/pharmamar-has-announced-that-the-spanish-medicines-agency-has-authorized-the-aplicov-pc-clinical-trial-with-aplidin-plitidepsin-for-the-treatment-of-patients-with-covid-19-301048251.html
https://www.prnewswire.com/news-releases/pharmamar-signs-a-commercialization-and-distribution-license-agreement-for-aplidin-with-pint-pharma-international-685119921.html
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/03/news_detail_002925.jsp&mid=WC0b01ac058004d5c1
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/01/news_detail_002888.jsp&mid=WC0b01ac058004d5c1
https://www.prnewswire.com/news-releases/pharmamar-firma-un-acuerdo-de-licencia-de-comercializacion-y-distribucion-para-aplidin-plitidepsina-con-megapharm-en-israel-667694613.html
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/12/news_detail_002867.jsp&mid=WC0b01ac058004d5c1
https://www.prnewswire.com/news-releases/plitidepsin-pharmamar-shows-activity-against-the-cells-responsible-for-the-destruction-of-bone-in-myeloma-multiple-663659083.html
Market Place
Share 
